v::RET
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | v::RET | Non-Small Cell Lung Cancer | Pralsetinib | |
| FDA (1) | v::RET | Papillary Thyroid Cancer | Pralsetinib | |
| FDA (1) HC (1) | v::RET | Non-Small Cell Lung Cancer | Selpercatinib | |
| FDA (1) | v::RET | Anaplastic Thyroid Cancer | Selpercatinib | |
| FDA (1) | v::RET | Any solid tumor | Selpercatinib | |
| HC (1) | v::RET | Papillary Thyroid Cancer | Selpercatinib |